First, we assessed and compared the feasibility and the efficacy of salvage nodal involved-field radiation therapy (s-IFRT) and salvage nodal extended-field radiation therapy (s-EFRT) in patients with FCH or PSMA PET-positive nodal recurrence from prostate cancer. The gene discussed is FOLH1; the disease is prostate carcinoma.